|
ADAR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.72499808776183E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.01616501271928E-12 |
| Normal-vs-Stage2 |
1.400400E-03 |
| Normal-vs-Stage3 |
2.268000E-02 |
| Normal-vs-Stage4 |
4.191500E-02 |
| Stage1-vs-Stage2 |
2.284200E-01 |
| Stage1-vs-Stage3 |
1.055580E-02 |
| Stage1-vs-Stage4 |
4.943400E-01 |
| Stage2-vs-Stage3 |
4.316200E-01 |
| Stage2-vs-Stage4 |
8.813000E-01 |
| Stage3-vs-Stage4 |
4.705000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.19370069384672E-11 |
| Normal-vs-AfricanAmerican |
5.26319998694902E-09 |
| Normal-vs-Asian |
1.419020E-01 |
| Caucasian-vs-AfricanAmerican |
9.114000E-01 |
| Caucasian-vs-Asian |
8.122600E-01 |
| AfricanAmerican-vs-Asian |
8.280600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77302617032637E-13 |
| Normal-vs-Female |
1.087500E-02 |
| Male-vs-Female |
1.369310E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.68489999996524E-06 |
| Normal-vs-Extreme_Weight |
1.64068758579106E-12 |
| Normal-vs-Obese |
1.67314999999224E-05 |
| Normal-vs-Extreme_Obese |
2.14669999998307E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.578810E-01 |
| Normal_Weight-vs-Obese |
3.259400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.451200E-01 |
| Extreme_Weight-vs-Obese |
3.616700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.859800E-01 |
| Obese-vs-Extreme_Obese |
1.575170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.607600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.20890000232521E-08 |
| Normal-vs-Age(61-80Yrs) |
2.29416485808542E-12 |
| Normal-vs-Age(81-100Yrs) |
3.49089979145845E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.116400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.375000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.680100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.768400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.041800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.773600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.75925940482102E-12 |
| Normal-VS-Type2 PRCC |
6.44740000055322E-07 |
| Normal-VS-KIRP CIMP |
7.602200E-01 |
| Normal-VS-Unclassified PRCC |
2.262800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.602000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.524980E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.183710E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.802300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.353600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.842000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.24830035197476E-10 |
| Normal-vs-N1 |
6.593000E-01 |
| Normal-vs-N2 |
7.503600E-01 |
| N0-vs-N1 |
7.099000E-03 |
| N0-vs-N2 |
4.477700E-02 |
| N1-vs-N2 |
9.478600E-01 |
|
|
